Dennis Mulroy
Director of Finance/CFO chez ANAPTYSBIO, INC.
Fortune : 21 709 $ au 31/03/2024
Profil
Dennis M.
Mulroy is currently the Chief Financial Officer at AnaptysBio, Inc. He was previously the CEO, Chief Financial & Accounting Officer at La Jolla Pharmaceutical Co. from 2015 to 2020.
Prior to that, he was the Chief Financial Officer, Treasurer & Director at Tissue Repair Co. from 2006 to 2013, and the Chief Financial Officer at Aries Ventures, Inc. from 2005 to 2006.
He also held the position of Chief Financial Officer at Molecular Imaging Corp.
from 2004 to 2005 and at SeraCare Life Sciences, Inc. from 2001 to 2003.
Additionally, he was the Chief Financial Officer at Taxus Cardium Pharmaceuticals Group, Inc. from 2005 to 2015 and at Bioceutix, Inc. in 2001.
He received his undergraduate degree from the University of San Diego in 1978.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANAPTYSBIO, INC.
0,00% | 30/01/2024 | 964 ( 0,00% ) | 21 709 $ | 31/03/2024 |
Postes actifs de Dennis Mulroy
| Sociétés | Poste | Début |
|---|---|---|
| ANAPTYSBIO, INC. | Director of Finance/CFO | 15/07/2020 |
Anciens postes connus de Dennis Mulroy
| Sociétés | Poste | Fin |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Executive Officer | 31/05/2020 |
| GENE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 03/04/2015 |
Tissue Repair Co.
 Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Director of Finance/CFO | 02/01/2013 |
| Aries Ventures, Inc. | Director of Finance/CFO | 23/01/2006 |
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Director of Finance/CFO | 04/11/2005 |
Formation de Dennis Mulroy
| University of San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
| Aries Ventures, Inc. | Finance |
Molecular Imaging Corp.
Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Health Services |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Health Technology |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
| Bioceutix, Inc. |
